Outcome of the Board Meeting held on Tuesday 18th February, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation. 2015

pdf

Gujarat Inject (Kerala) Ltd.

13 Feb 2025

27.99

2.83%

Board Meeting

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Sub- Division/Split Of The Equity …

BSE India

GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/02/2025 ,inter alia, to consider and approve proposal for sub- division/split of the equity shares of the Company, in such manner, as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities, as may be required

pdf

Gujarat Inject (Kerala) Ltd.

05 Feb 2025

27.99

2.83%

Board Meeting

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e., Wednesday, 5th February, 2025, could not come to conclusion on the subject matter of Stock Split/sub-division of the equity shares of the company due to some technical and unavoidable circumstances.

pdf

Gujarat Inject (Kerala) Ltd.

01 Feb 2025

27.99

2.83%

Board Meeting

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Sub- Division/Split Of The Equity …

BSE India

GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 ,inter alia, to consider and approve proposal for sub- division/split of the equity shares of the Company, in such manner, as may be determined by the Board of Directors and subject to approval of the Shareholders and such authorities, as may be required

pdf

Gujarat Inject (Kerala) Ltd.

23 Jan 2025

27.99

2.83%

Result

GUJARAT INJECT (KERALA) LTD. - 524238 - Unaudited Financial Results Of The Company For The Quarter …

BSE India

Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion)

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	3.15	8.78	0.25	-64.1%	1160.0%
Operating Profit Qtr	0.28	0.54	-0.03	-48.1%	1033.3%
Net Profit Qtr	0.21	0.61	0.00	-65.6%	-
Earning Per Share Adjusted latest Qtr	0.14	0.42	0.00	-66.7%	-

* Standalone data

Detailed Results

Gujarat Inject (Kerala) Ltd.

23 Jan 2025

27.99

2.83%

Board Meeting

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Outcome for Outcome Of Board Meeting Held …

BSE India

In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on January 23, 2025, at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:20 P.M., have, apart from other businesses, 1) Considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report (Unmodified Opinion) In this regards, we are hereby submitting the followings: 1. Unaudited Financial Results for the quarter and nine months ended on December 31, 2024; 2. Limited review report; Kindly take the same on your record and oblige us.

More...

pdf

Gujarat Inject (Kerala) Ltd.

18 Jan 2025

27.99

2.83%

Board Meeting

GUJARAT INJECT (KERALA) LTD. - 524238 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled …

BSE India

GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve & take on record the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and any other items as may be decided by the Board of Directors.

More...

pdf